U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07595042) titled 'A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)' on May 06.
Brief Summary: The A5414 study will evaluate whether treatment for drug-susceptible pulmonary tuberculosis (TB) can be tailored according to a participant's risk of an unfavorable outcome. Participants will be assigned to lower-risk or higher-risk groups using baseline characteristics and then randomized within each group to receive either standard TB treatment or an investigational rifapentine- and moxifloxacin-containing regimen. The study will evaluate whether shorter treatment durations may be used in lower-risk participants and wheth...